You are here
Clinical Trials: Vascular Disease
Each Clinical Trial will open in a new browser window or tab.
Condition: Ischemic Stroke
Intervention: Biological: MSC
Sponsor: Shanghai IxCell Biotechnology Co., LTD
Not yet recruiting
Intervention: Biological: MSC
Sponsor: Shanghai IxCell Biotechnology Co., LTD
Not yet recruiting
Conditions: Multiple System Atrophy; MSA - Multiple System Atrophy
Interventions: Drug: hOMSC300; Other: Sham Procedure
Sponsor: Cytora Ltd.
Recruiting
Interventions: Drug: hOMSC300; Other: Sham Procedure
Sponsor: Cytora Ltd.
Recruiting
Conditions: Myocardial Infarction; Myocardial Ischemia; Myocardial Stunning
Intervention: Biological: mitochondria and MSC-derived exosomes
Sponsor: Tehran University of Medical Sciences
Recruiting
Intervention: Biological: mitochondria and MSC-derived exosomes
Sponsor: Tehran University of Medical Sciences
Recruiting
Conditions: Ischemic Heart Disease; Ischemic Cardiomyopathy; Heart Failure, Systolic; Heart Failure NYHA Class III; Heart Failure NYHA Class II; Heart Failure NYHA Class IV; Coronary Artery Disease
Interventions: Procedure: Epicardial AAMs-patch transplantation; Diagnostic Test: RNA-stabilized whole blood sampling; Diagnostic Test: Plasma sampling; Diagnostic Test: Transthoracic echocardiography; Diagnostic Test: Late-gadolinium enhancement cardiac magnetic resonance imaging (LGE-CMRI); Other: Symptom-scaling; Other: 6-minute walking test (6MWT); Diagnostic Test: Blood sampling (NT-proBNP); Diagnostic Test: Transesophageal echocardiography
Sponsors: Hospital District of Helsinki and Uusimaa; University of Helsinki
Not yet recruiting
Interventions: Procedure: Epicardial AAMs-patch transplantation; Diagnostic Test: RNA-stabilized whole blood sampling; Diagnostic Test: Plasma sampling; Diagnostic Test: Transthoracic echocardiography; Diagnostic Test: Late-gadolinium enhancement cardiac magnetic resonance imaging (LGE-CMRI); Other: Symptom-scaling; Other: 6-minute walking test (6MWT); Diagnostic Test: Blood sampling (NT-proBNP); Diagnostic Test: Transesophageal echocardiography
Sponsors: Hospital District of Helsinki and Uusimaa; University of Helsinki
Not yet recruiting
Conditions: Myocardial Reperfusion Injury; Treatment Outcome; Prognosis; ST Elevation Myocardial Infarction
Intervention: Device: Extracorporeal cardiac shock wave therapy(ECSW)
Sponsor: The First Affiliated Hospital of Kunming Medical College
Not yet recruiting
Intervention: Device: Extracorporeal cardiac shock wave therapy(ECSW)
Sponsor: The First Affiliated Hospital of Kunming Medical College
Not yet recruiting
Conditions: Diabetic Foot Ulcer; Mesenchymal Stromal Cells
Intervention: Drug: Adipose tissue derived mesenchymal stromal/stem cells (Cell2Cure®)
Sponsor: Cell2Cure ApS
Not yet recruiting
Intervention: Drug: Adipose tissue derived mesenchymal stromal/stem cells (Cell2Cure®)
Sponsor: Cell2Cure ApS
Not yet recruiting
Condition: Ischemic Bowel Disease
Intervention: Other: Human Umbilical Cord blood mononuclear cells
Sponsor: Qianfoshan Hospital
Recruiting
Intervention: Other: Human Umbilical Cord blood mononuclear cells
Sponsor: Qianfoshan Hospital
Recruiting
Condition: Venous Leg Ulcer
Interventions: Biological: XSTEM-VLU; Other: Vehicle
Sponsors: Xintela AB; Vinnova
Not yet recruiting
Interventions: Biological: XSTEM-VLU; Other: Vehicle
Sponsors: Xintela AB; Vinnova
Not yet recruiting
Conditions: Hypoxic-Ischemic Encephalopathy; Neonatal Asphyxia; Neonatal Encephalopathy
Interventions: Drug: Normal Saline along with standard treatment; Drug: Sovateltide along with standard treatment
Sponsor: Pharmazz, Inc.
Not yet recruiting
Interventions: Drug: Normal Saline along with standard treatment; Drug: Sovateltide along with standard treatment
Sponsor: Pharmazz, Inc.
Not yet recruiting
Conditions: Heart Disease, Ischemic; Hyperlipidemias; Hypertension
Intervention: Other: Whole-Food, Plant-Based Diet and Low-Carbohydrate Diet
Sponsor: University of Rochester
Not yet recruiting
Intervention: Other: Whole-Food, Plant-Based Diet and Low-Carbohydrate Diet
Sponsor: University of Rochester
Not yet recruiting